12:45pm ET
Health and Healthcare
Is a Big Share Buyback Coming to DaVita?
DaVita Healthcare Partners has a large amount of cash on its balance sheet and it does not pay a dividend. Should investors should expect a big stock buyback?
AMGN Coverage Page 30
8:15am ET
Health and Healthcare
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech companies could have some very import clinical data releases.
9:15am ET
Health and Healthcare
Short Sellers Get More Aggressive on Big Biotech
24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with the mid-February figures. Across the board, all the selected stocks have seen…
9:25am ET
Health and Healthcare
Short Sellers Increase Bets Against Biotech as Shares Continue to Rise
The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
8:25am ET
Health and Healthcare
Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015
Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid pipelines and, most importantly, earnings.
9:40am ET
Health and Healthcare
Short Sellers Look Scared of Big Biotech
The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
9:10am ET
Investing
Insiders Aggressively Buy Shares as Market Rockets Higher
Logically, it seems that as they stock market zooms higher, insiders who want to buy stock would wait until a pullback to add new capital.
10:45am ET
Health and Healthcare
Gilead Dividend and Buyback Different From Amgen’s Strategy
Gilead Sciences has become so large and accumulated enough capital that it has decided to begin paying a dividend, a move follows Amgen.
11:00am ET
Health and Healthcare
Short Sellers Starting to Gang Up on Biotech
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected stocks, short interest is down.
8:55am ET
Health and Healthcare
Short Interest in Biotechs Signals Optimism
24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.
1:05pm ET
Health and Healthcare
Is a Biosimilar (Generic) Top Cancer Drug for You?
A biosimilar application filing from Apotex has been accepted by the Food and Drug Administration for version of Amgen's Neulasta.
10:00am ET
Health and Healthcare
Are Investors Signaling Optimism in Biotechs Through Short Interest?
The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top biotech companies.
11:07am ET
Health and Healthcare
Mixed Readings For Biotech Short Interest
ThinkstockThe short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or…
10:23am ET
Health and Healthcare
Amgen Surprise, Discontinues Stomach Cancer Drug Study
ThinkstockAmgen Inc. (NASDAQ: AMGN) announced the termination of all Amgen-sponsored clinical studies of rilotumumab in advanced gastric cancer. This includes phase 3 RILOMET-1 and RILOMET-2 studies. The decision to discontinue was made…
Chris Lange 8:40am ET
Health and Healthcare
Biotech Short Interest Becomes Stock Specific (Updated)
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.